Harvey Investment Company’s Thermo Fisher Scientific TMO Stock Holding History

Harvey Investment Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-511	Closed	-$251K	–	101
2026 Q1	$251K	Hold	511	–	–	0.03%	94
2025 Q4	$296K	Hold	511	–	–	0.03%	89
2025 Q3	$248K	Hold	511	–	–	0.03%	99
2025 Q2	$207K	Hold	511	–	–	0.02%	101
2025 Q1	$254K	Hold	511	–	–	0.03%	96
2024 Q4	$266K	Hold	511	–	–	0.03%	93
2024 Q3	$316K	Hold	511	–	–	0.04%	87
2024 Q2	$283K	Hold	511	–	–	0.03%	88
2024 Q1	$297K	Hold	511	–	–	0.03%	85
2023 Q4	$271K	Hold	511	–	–	0.03%	83
2023 Q3	$259K	Hold	511	–	–	0.03%	83
2023 Q2	$267K	Hold	511	–	–	0.03%	83
2023 Q1	$295K	Hold	511	–	–	0.04%	82
2022 Q4	$281K	Hold	511	–	–	0.04%	84
2022 Q3	$259K	Hold	511	–	–	0.04%	84
2022 Q2	$278K	Hold	511	–	–	0.04%	82
2022 Q1	$302K	Hold	511	–	–	0.04%	83
2021 Q4	$341K	Hold	511	–	–	0.04%	83
2021 Q3	$292K	Hold	511	–	–	0.04%	83
2021 Q2	$258K	Hold	511	–	–	0.03%	88
2021 Q1	$233K	Hold	511	–	–	0.03%	90
2020 Q4	$238K	Hold	511	–	–	0.03%	88
2020 Q3	$226K	Buy	+511	New	+$211K	0.04%	86

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Harvey Investment Company's TMO Position: Q2 2026 in Review

Harvey Investment Company sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 511 shares — an estimated $251K sold.

Harvey Investment Company first reported a position in TMO in Q3 2020 and held it in 23 quarters. The position peaked at $341K in Q4 2021. 994 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Harvey Investment Company reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Harvey Investment Company sold 511 Thermo Fisher Scientific shares in Q2 2026, an estimated $251K.
Harvey Investment Company first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 23 quarters.
Harvey Investment Company's Thermo Fisher Scientific position peaked at $341K in Q4 2021.
994 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Harvey Investment Company's 13F filing for Q2 2026, filed 22 Jul 2026.